Jimenez, Freyannah M.

HRN: 29-26-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
07/02/2026
07/09/2026
IV
150mg
Q6
PCAP C
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: